Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • Leadership
    • Team
    • Publications
    • Careers
  • Diseases/Disorders
    • One Brain
    • ALS
    • Alzheimer’s
    • Autism
    • Brain Cancer
    • Brain Injury
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • Other
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
  • Ways To Give
    • Your Impact
    • How You Can Help
    • Events

Funded Grants

Back to results

Integrative discovery of ion channels as drug targets in glioblastoma

Project Overview

Ion channel (IC) proteins are known to be involved in different human diseases such as heart and brain disorders. There are many drugs that activate or inactivate ICs and they are used to treat patients with these diseases. However, less has been known about the role of ICs in cancer and no approved IC drugs are used to treat cancer.

Dr. Reimand and his team’s recent findings have shown that ICs are important in brain and other cancers, suggesting that IC drugs can be also used in cancer treatment. For this particular project the team will analyze all human ICs using genetic information from thousands of cancer patients with dozens of cancer types. They will focus on glioblastoma, an aggressive and currently incurable brain cancer. Their statistical approach will identify the most promising ICs that can be used for cancer treatment with existing drugs. Having identified candidate ICs, they will perform experiments using flies, mice, brain cancer cells and known IC drugs to understand the role of ICs in brain cancer and prove that IC drugs can be used for treatment. The overall objective of this project is to find the ICs that are most important in brain cancer and the IC drugs that can reduce brain tumour growth. This knowledge will rapidly enable clinical trials to study the use of IC drugs to treat cancer patients.

Principal Investigator

Juri Reimand , Ontario Institute for Cancer Research

Partners and Donors

Canadian Cancer Society

Project Ongoing

Integrative discovery of ion channels as drug targets in glioblastoma

  • Program Type

    Team grants

  • Area of research

    Cancer

  • Disease Area

    Brain Cancer

  • Competition

    Canadian Cancer Society Innovation Grants

  • Province

    Ontario

  • Start Date

    2017

  • Total Grant Amount

    $196,000

  • Health Canada Contribution

    $98,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign up

© 2023 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co